NCT06429800 2025-04-24A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus ErythematosusAtara BiotherapeuticsPhase 1 Withdrawn
NCT01931644 2024-04-18At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsSanguine BiosciencesCompleted17,667 enrolled
NCT00447265 2013-02-12Etanercept for the Treatment of Lupus NephritisNational Institute of Allergy and Infectious Diseases (NIAID)Phase 2 Terminated1 enrolled 15 charts